Login
Menu
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
CE Applications
Links
Login
Enduring Material
HER 2 + Breast Cancer
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
7600 Central Avenue
Philadelphia, PA 19111
General Information
Active Dates
Monday, February 7, 2022 - Saturday, December 31, 2022
Conference Host
Fox Chase Cancer Center
Conference Location
Virtual Conference Room
Conference Name
20th Annual Highlights of the 2021 San Antonio Breast Cancer Symposium
Provider
Temple Health
Watch this Lecture Remotely
Other Comments
References - available in the presentation slides.
Objectives
Series Objectives
Analyze the advances in the management of breast cancer and premalignant breast disease and, when clinically relevant, integrate new findings into the management of patients with breast cancer and premalignant breast disease.
When clinically relevant, apply new strategies for optimizing existing treatments into the management of these patients.
Analyze new developments in breast cancer research and current available clinical trials and when clinically relevant, include this information in discussions with patients.
Presentations and Speakers
Presentation #1
HER 2 + Breast Cancer
Lori J Goldstein, MD
Available Credits/Points
Credit Designation
Temple Health designates this enduring material for a maximum of 0.5
AMA PRA Category 1 Credits
. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
Disclosure Statements
Series Disclosures
Lori J Goldstein, MD, Program Director, has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
• Daiichi Sankyo - DSMB - Relationship Has Not Ended
• Genentech - Advisory Committee Member - Relationship Ended
• Eisai - Advisory Committee Member - Relationship Has Not Ended
• Astra Zeneca - Advisory Committee Member - Relationship Ended
• Merck - Advisory Committee Member - Relationship Has Not Ended
• Exact Sciences - Advisory Committee Member - Relationship Ended
• Immunomedics - Advisory Committee Member - Relationship Ended
• Biovica Divitum - Advisory Committee Member - Relationship Ended
All relevant financial relationships with ineligible companies have been mitigated.
Event Disclosures
Planners and other Administrative Support:
Lori J Goldstein, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
Daiichi Sankyo - DSMB - Relationship Has Not Ended
Genentech - Advisory Committee Member - Relationship Ended
Eisai - Advisory Committee Member - Relationship Has Not Ended
Astra Zenica - Advisory Committee Member - Relationship Ended
MERCK - Advisory Committee Member - Relationship Has Not Ended
Exact Sciences - Advisory Committee Member - Relationship Ended
Immunomedics - Advisory Committee Member - Relationship Ended
Biovica Divitum - Advisory Committee Member - Relationship Ended
All of the relevant financial relationships listed for these individuals have been mitigated.
Accreditation Statement
Temple Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
Test Information
Percentage of Correct Responses Required to Pass
80 %
Percentage of Responses Required to Submit
100 %
Last Review Date
2/7/2022
Continue to Enduring Material
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement